With RFK Jr. nominated for Secretary of the Department of Health & Human Services, these are all the agencies, including the ...

Doctors recommend avoiding NSAIDs after a flu vaccination because these can dampen the immune response by slashing the ...

The US Food and Drug Administration (FDA) has approved Azurity Pharmaceuticals’ Danziten (nilotinib), the first and only ...

Seattle's Zillow Group announced a new COO, while Vouched hired a new CTO. Fred Hutch created and filled the new title of ...

Speaker of the House Mike Johnson says releasing the ethics committee report on the Florida lawmaker would set "a terrible ...

HCW Biologics Inc. (the "Company" or "HCW Biologics") (NASDAQ: HCWB), a clinical-stage biopharmaceutical company focused on discovering and developing ...

Adaptimmune’s Phase II IGNYTE-ESO trial investigating experimental T cell therapy lete-cel has achieved its primary endpoint.

Danziten is a twice daily, oral medication that inhibits the BCR-ABL tyrosine kinase. Nilotinib was originally approved under the brand name Tasigna; it is currently indicated for adults and pediatric ...

Understanding what to patent versus what to keep as a trade secret is an increasingly important and challenging decision ...

Bob Jones University covers tuition for some South Carolina residents. Samaritan Biologics expands its Greenville factory. Goodwill revamps Upstate presence.

The FDA has provided a date of April 18, 2025, to review the application for Dupixent to treat patients with chronic ...

The intrigue on Capitol Hill has been fueled by increased public interest in the topic, as some videos of UAPs have become ...